Retooling drug development with next-generation machine learning, Owkin nabs $11M – FierceBiotech
machine learning machine learning deployment
Retooling drug development with next-generation machine learning, Owkin nabs $11M – FierceBiotech
FierceBiotechRetooling drug development with next-generation machine learning, Owkin nabs $11MFierceBiotechUnlike many other AI-based drug development platforms, Owkin Socrates utilizes two machine learning tools—transfer learning and federated learnin...
machine learning machine learning deployment

Retooling drug development with next-generation machine learning, Owkin nabs $11M – FierceBiotech


FierceBiotech
Retooling drug development with next-generation machine learning, Owkin nabs $11M
FierceBiotech
Unlike many other AI-based drug development platforms, Owkin Socrates utilizes two machine learning tools—transfer learning and federated learning. Gilles Wainrib, PhD., co-founder and CSO of Owkin, explained to FierceBiotech via email how they work ...

and more »